BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

789 related articles for article (PubMed ID: 18164261)

  • 21. RNA interference (RNAi) with RNase III-prepared siRNAs.
    Yang D; Goga A; Bishop JM
    Methods Mol Biol; 2004; 252():471-82. PubMed ID: 15017072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Picking a winner: new mechanistic insights into the design of effective siRNAs.
    Gong D; Ferrell JE
    Trends Biotechnol; 2004 Sep; 22(9):451-4. PubMed ID: 15331225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Strand-specific silencing of a picornavirus by RNA interference: evidence for the superiority of plus-strand specific siRNAs.
    Schubert S; Rothe D; Werk D; Grunert HP; Zeichhardt H; Erdmann VA; Kurreck J
    Antiviral Res; 2007 Mar; 73(3):197-205. PubMed ID: 17112603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Dicer efficiently converts large dsRNAs into siRNAs suitable for COX-2 gene].
    Luo H; Hu DX; Chen P
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 32(3):437-42. PubMed ID: 17611321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of siRNAs that contain internal variable-length spacer linkages.
    Efthymiou TC; Peel B; Huynh V; Desaulniers JP
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5590-4. PubMed ID: 22850216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of assembly of siRNA elements into RNA-induced silencing complex by fork-siRNA duplex carrying nucleotide mismatches at the 3'- or 5'-end of the sense-stranded siRNA element.
    Ohnishi Y; Tokunaga K; Hohjoh H
    Biochem Biophys Res Commun; 2005 Apr; 329(2):516-21. PubMed ID: 15737617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [RNA binding proteins in the RNA interference phenomenon].
    Kotel'nikov RN; Shpiz SG; Kalmykova AI; Gvozdev VA
    Mol Biol (Mosk); 2006; 40(4):595-608. PubMed ID: 16913219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Passenger-strand cleavage facilitates assembly of siRNA into Ago2-containing RNAi enzyme complexes.
    Matranga C; Tomari Y; Shin C; Bartel DP; Zamore PD
    Cell; 2005 Nov; 123(4):607-20. PubMed ID: 16271386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combinatorial delivery of small interfering RNAs reduces RNAi efficacy by selective incorporation into RISC.
    Castanotto D; Sakurai K; Lingeman R; Li H; Shively L; Aagaard L; Soifer H; Gatignol A; Riggs A; Rossi JJ
    Nucleic Acids Res; 2007; 35(15):5154-64. PubMed ID: 17660190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. siRNAs and shRNAs: skeleton keys to the human genome.
    Paddison PJ; Hannon GJ
    Curr Opin Mol Ther; 2003 Jun; 5(3):217-24. PubMed ID: 12870430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Argonaute2, a link between genetic and biochemical analyses of RNAi.
    Hammond SM; Boettcher S; Caudy AA; Kobayashi R; Hannon GJ
    Science; 2001 Aug; 293(5532):1146-50. PubMed ID: 11498593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of RNA interference by adenovirus virus-associated RNA.
    Andersson MG; Haasnoot PC; Xu N; Berenjian S; Berkhout B; Akusjärvi G
    J Virol; 2005 Aug; 79(15):9556-65. PubMed ID: 16014917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression profiling reveals off-target gene regulation by RNAi.
    Jackson AL; Bartz SR; Schelter J; Kobayashi SV; Burchard J; Mao M; Li B; Cavet G; Linsley PS
    Nat Biotechnol; 2003 Jun; 21(6):635-7. PubMed ID: 12754523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Viral RNAi suppressor reversibly binds siRNA to outcompete Dicer and RISC via multiple turnover.
    Rawlings RA; Krishnan V; Walter NG
    J Mol Biol; 2011 Apr; 408(2):262-76. PubMed ID: 21354178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro assembly of plant RNA-induced silencing complexes facilitated by molecular chaperone HSP90.
    Iki T; Yoshikawa M; Nishikiori M; Jaudal MC; Matsumoto-Yokoyama E; Mitsuhara I; Meshi T; Ishikawa M
    Mol Cell; 2010 Jul; 39(2):282-91. PubMed ID: 20605502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of target site accessibility on the design of effective siRNAs.
    Tafer H; Ameres SL; Obernosterer G; Gebeshuber CA; Schroeder R; Martinez J; Hofacker IL
    Nat Biotechnol; 2008 May; 26(5):578-83. PubMed ID: 18438400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploring chemical modifications for siRNA therapeutics: a structural and functional outlook.
    Shukla S; Sumaria CS; Pradeepkumar PI
    ChemMedChem; 2010 Mar; 5(3):328-49. PubMed ID: 20043313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The design, preparation, and evaluation of asymmetric small interfering RNA for specific gene silencing in mammalian cells.
    Chang C; Hong SW; Dua P; Kim S; Lee DK
    Methods Mol Biol; 2013; 942():135-52. PubMed ID: 23027049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SiRNAs conjugated with aromatic compounds induce RISC-mediated antisense strand selection and strong gene-silencing activity.
    Kubo T; Yanagihara K; Takei Y; Mihara K; Sato Y; Seyama T
    Biochem Biophys Res Commun; 2012 Oct; 426(4):571-7. PubMed ID: 22982308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene silencing in human embryonic stem cells by RNA interference.
    Rassouli FB; Matin MM
    Biochem Biophys Res Commun; 2009 Dec; 390(4):1106-10. PubMed ID: 19833094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.